Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044

Non-melanoma skin cancers (NMSC) are the most common malignancies worldwide and are, worryingly, increasing in incidence. However, data in the literature on NMSC specific mortality are scarce, because these tumors are excluded from most mortality registries. The main objective of this study is to an...

Full description

Bibliographic Details
Main Authors: Mercedes Sendín-Martin, Juan Carlos Hernández-Rodríguez, Antonio-José Durán-Romero, Juan Ortiz-Álvarez, Julian Conejo-Mir, José-Juan Pereyra-Rodríguez
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/24/5750
_version_ 1797503535005302784
author Mercedes Sendín-Martin
Juan Carlos Hernández-Rodríguez
Antonio-José Durán-Romero
Juan Ortiz-Álvarez
Julian Conejo-Mir
José-Juan Pereyra-Rodríguez
author_facet Mercedes Sendín-Martin
Juan Carlos Hernández-Rodríguez
Antonio-José Durán-Romero
Juan Ortiz-Álvarez
Julian Conejo-Mir
José-Juan Pereyra-Rodríguez
author_sort Mercedes Sendín-Martin
collection DOAJ
description Non-melanoma skin cancers (NMSC) are the most common malignancies worldwide and are, worryingly, increasing in incidence. However, data in the literature on NMSC specific mortality are scarce, because these tumors are excluded from most mortality registries. The main objective of this study is to analyze NMSC’s mortality rates and use them to generate a predictive model for the coming years in Spain. Data on mid-year population and death certificates for the period 1979–2019 were obtained from the Spanish National Statistics Institute. The Nordpred program (Cancer Registry of Norway, Oslo, Norway) within statistical program R was used to calculate mortality adjusted rates, as well as the mortality projection with an age-period-cohort model. This is the first study to report a prediction about NMSC mortality in the next years. According to our findings, the number of NMSC deaths in older people will grow in both sexes, especially in those older than >85 years old (y.o.). The age-specific mortality rates of NMSC will tend to stabilize or gradually decrease, with the exception of women between 75–79 y.o., who will present a slight increase at the end of the period. Early prevention and screening of NMSC specifically oriented to this population might change this tendency.
first_indexed 2024-03-10T03:52:03Z
format Article
id doaj.art-cbbdb2fc19aa4e1c8d7965c477d76590
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T03:52:03Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-cbbdb2fc19aa4e1c8d7965c477d765902023-11-23T08:55:41ZengMDPI AGJournal of Clinical Medicine2077-03832021-12-011024575010.3390/jcm10245750Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044Mercedes Sendín-Martin0Juan Carlos Hernández-Rodríguez1Antonio-José Durán-Romero2Juan Ortiz-Álvarez3Julian Conejo-Mir4José-Juan Pereyra-Rodríguez5Dermatology Departement, Hospital Universitorio Virgen del Rocio, Avda. Manuel Siurot s/n., 41013 Sevilla, SpainDermatology Departement, Hospital Universitorio Virgen del Rocio, Avda. Manuel Siurot s/n., 41013 Sevilla, SpainDermatology Departement, Hospital Universitorio Virgen del Rocio, Avda. Manuel Siurot s/n., 41013 Sevilla, SpainDermatology Departement, Hospital Universitorio Virgen del Rocio, Avda. Manuel Siurot s/n., 41013 Sevilla, SpainDermatology Departement, Hospital Universitorio Virgen del Rocio, Avda. Manuel Siurot s/n., 41013 Sevilla, SpainDermatology Departement, Hospital Universitorio Virgen del Rocio, Avda. Manuel Siurot s/n., 41013 Sevilla, SpainNon-melanoma skin cancers (NMSC) are the most common malignancies worldwide and are, worryingly, increasing in incidence. However, data in the literature on NMSC specific mortality are scarce, because these tumors are excluded from most mortality registries. The main objective of this study is to analyze NMSC’s mortality rates and use them to generate a predictive model for the coming years in Spain. Data on mid-year population and death certificates for the period 1979–2019 were obtained from the Spanish National Statistics Institute. The Nordpred program (Cancer Registry of Norway, Oslo, Norway) within statistical program R was used to calculate mortality adjusted rates, as well as the mortality projection with an age-period-cohort model. This is the first study to report a prediction about NMSC mortality in the next years. According to our findings, the number of NMSC deaths in older people will grow in both sexes, especially in those older than >85 years old (y.o.). The age-specific mortality rates of NMSC will tend to stabilize or gradually decrease, with the exception of women between 75–79 y.o., who will present a slight increase at the end of the period. Early prevention and screening of NMSC specifically oriented to this population might change this tendency.https://www.mdpi.com/2077-0383/10/24/5750non-melanomaskin cancerepidemiology
spellingShingle Mercedes Sendín-Martin
Juan Carlos Hernández-Rodríguez
Antonio-José Durán-Romero
Juan Ortiz-Álvarez
Julian Conejo-Mir
José-Juan Pereyra-Rodríguez
Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044
Journal of Clinical Medicine
non-melanoma
skin cancer
epidemiology
title Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044
title_full Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044
title_fullStr Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044
title_full_unstemmed Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044
title_short Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044
title_sort non melanoma skin cancer mortality in spain a predictive model up to 2044
topic non-melanoma
skin cancer
epidemiology
url https://www.mdpi.com/2077-0383/10/24/5750
work_keys_str_mv AT mercedessendinmartin nonmelanomaskincancermortalityinspainapredictivemodelupto2044
AT juancarloshernandezrodriguez nonmelanomaskincancermortalityinspainapredictivemodelupto2044
AT antoniojoseduranromero nonmelanomaskincancermortalityinspainapredictivemodelupto2044
AT juanortizalvarez nonmelanomaskincancermortalityinspainapredictivemodelupto2044
AT julianconejomir nonmelanomaskincancermortalityinspainapredictivemodelupto2044
AT josejuanpereyrarodriguez nonmelanomaskincancermortalityinspainapredictivemodelupto2044